MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Genetic, biochemical and clinical findingss in Friedreich’s ataxia patients – relationship with the disease severity

    R. Moganty, D. Pathak, A. srivastava, s. Gulati (New Delhi, India)

    Objective: To investigate the correlation of disease severity in terms of clinical, genetic and molecular parameters in FRDA. Background: : Friedreich ataxia (FRDA) is a…
  • MDS Virtual Congress 2020

    An unusual phenotype of spinocerebellar ataxia type 12

    K. Neeraja, V. Holla, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To describe a case of spinocerebellar ataxia type 12 (SCA-12) with an unusual phenotype. Background: SCA-12 is a rare autosomal dominant cerebellar ataxia which…
  • MDS Virtual Congress 2020

    GAD65 antibody neurologic syndrome presenting with hemiparkinsonism

    R. Patel, N. Witek, P. Pinna, M. Afshari (Chicago, IL, USA)

    Objective: To describe a novel phenotype of glutamic acid decarboxylase-65 (GAD65) antibody-associated neurological disease in which an older patient initially presented with levodopa-unresponsive hemiparkinsonism and…
  • MDS Virtual Congress 2020

    Novel KCND3 mutation associated with paroxysmal motor exacerbations in spinocerebellar ataxia 19

    M. Paucar, R. Ågren, T. Li, S. Lissmats, Å. Bergendal, I. Savitcheva, D. Nilsson, K. Sahlholm, P. Svenningsson, J. Nilsson (Stockholm, Sweden)

    Objective: To investigate a family affected by ataxia and paroxysmal motor exacerbations. Background: Ataxia channelopathies share common traits such as slow progression and variable degree…
  • MDS Virtual Congress 2020

    Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7

    L. Pesantez Pacheco, N. Thakur (Houston, TX, USA)

    Objective: To report the therapeutic effects of amantadine in a patient with Spinocerebellar ataxia type 7 (SCA7) Background: Spinocerebellar ataxia type 7 is a rare…
  • MDS Virtual Congress 2020

    Two cases of Ataxia Telangiectasia Like Disorder: phenotypic spectrum associated with MRE11 gene

    I. Raslan, P. Matos, V. Ciarlarello, C. Jaques, J. Pedroso, O. Barsottini (São Paulo, Brazil)

    Objective: In this study we show a couple of siblings with a progressive cerebellar ataxia associated with mutation in MRE11A. Our goal is to demonstrate…
  • MDS Virtual Congress 2020

    A Novel CACNA1A Nonsense Variant [c.6481C>G; (p.Arg2161Gly)] Causing Spino Cerebellar Ataxia Type 6 (SCA6)

    J.P Romero, J. Herreros, S. Santillán, Y. Moreno, A. Andújar (Madrid, Spain)

    Objective: To describe a new missense variant found in a 67 years old woman with progressive ataxia causing a phenotype compatible with SCA 6. Background:…
  • MDS Virtual Congress 2020

    Ataxia and action myoclonus with biallelic mutations in ATP13A2 gene

    A. Sánchez-Rodríguez, I. González-Aramburu, M. Sierra, A.L Pelayo-Negro, M. Corral-Juan, X. Farré, I. Sánchez, A. Matilla-Dueñas, J. Infante (Santander, Spain)

    Objective: Here we report a patient with late-onset ataxia-myoclonus syndrome harboring mutations in the ATP13A2 gene. Background: Mutations in ATP13A2 gene have been causally associated…
  • MDS Virtual Congress 2020

    Clinical features of impaired communication in patients with multiple system atrophy

    T. Shimohata, M. Yamada, M. Hotta, Y. Ohno, H. Shibata, M. Yasunishi, Y. Suzuki, Y. Hayashi, A. Kimura (Aichi, Japan)

    Objective: This study aimed to clarify the characteristics of communication impairment, its influencing factors, and availability of communication tools in patients with multiple system atrophy…
  • MDS Virtual Congress 2020

    An uncommon clinical phenotype associated with ANO10 mutation

    D. Silva, L. Guedes, A. Caldas (Torres Vedras, Portugal)

    Objective: To describe a case with a homozygous c.132dupA ANO10 mutation. Background: Autosomal recessive cerebellar ataxia type 3 (ARCA3) is associated to ANO10 mutations. It…
  • « Previous Page
  • 1
  • …
  • 758
  • 759
  • 760
  • 761
  • 762
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley